Rosiglitazone Sodium
罗格列酮钠
Report date: 2024/07/02 12:24:40
Base Information
Drug NameRosiglitazone Sodium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2004/09/14
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaiji Group Co Ltd
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A